| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |